{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:03:07Z","timestamp":1791306187975,"version":"4.3.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Uterine fibroid and benign thyroid disease are both common diseases in women. This study aimed to evaluate whether these diseases are related. We established the uterine fibroid group according to diagnosis and surgery codes using the Korea National Health Insurance data from 2009 to 2020. All women from 20 to 50\u00a0years old who underwent uterine myomectomy from 2009 to 2020 were identified. We selected the control group by performing a 1:1 propensity score matching on age at 5-year intervals, socioeconomic status (SES), region, Charlson comorbidity index (CCI), menopause, and year among women who visited a medical institution for a health check-up. Thyroid disease cases were selected using the thyroid disease diagnosis code and thyroid-associated laboratory tests. A total of 181,419 patients were included in the uterine fibroid and control groups. The median age of each group was 40 (range, 35\u2009~\u200944) and 40 (range, 35\u2009~\u200945) years old, respectively. Benign thyroid disease affected 1162 (0.6%) in the uterine fibroid group and 1137 (0.6%) in the control group. Among the benign thyroid diseases, hypothyroidism was the most common in both groups, followed by a nontoxic single thyroid nodule. The uterine fibroid group had a higher risk of thyroid goiter (hazard ratio (HR) 1.169, 95% confidence interval (CI) 1.022\u20131.338), nontoxic single thyroid nodule (HR 1.268, 95% CI 1.182\u20131.361), and total thyroid disease (HR 1.078, 95% CI 1.036\u20131.121) in stratified Cox regression analysis adjusted for age, SES, region, CCI, parity, menopause, hypertension, diabetes, dyslipidemia, systemic lupus erythematosus, irritable bowel syndrome, Crohn\u2019s disease, and endometriosis than the control group. The results suggest that women with uterine fibroids have an increased risk of thyroid goiters and thyroid nodules. Although the mechanism is not well known, estrogen and iodide might be a link between uterine fibroids and thyroid goiters and nodules. Future studies that prospectively follow women with uterine fibroids across a lifetime are needed.<\/jats:p>","DOI":"10.1038\/s41598-022-10625-x","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T10:09:45Z","timestamp":1650622185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Uterine fibroids increase the risk of thyroid goiter and thyroid nodules"],"prefix":"10.1038","volume":"12","author":[{"given":"Jin-Sung","family":"Yuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"10625_CR1","doi-asserted-by":"publisher","first-page":"16043","DOI":"10.1038\/nrdp.2016.43","volume":"2","author":"EA Stewart","year":"2016","unstructured":"Stewart, E. A. et al. Uterine fibroids: Review. Nat. Rev. Dis. Primers. 2, 16043. https:\/\/doi.org\/10.1038\/nrdp.2016.43 (2016).","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"3","key":"10625_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.7326\/0003-4819-69-3-537","volume":"69","author":"JB Vander","year":"1968","unstructured":"Vander, J. B., Gaston, E. A. & Dawber, T. R. The significance of nontoxic thyroid nodules: Final report of a 15-year study of the incidence of thyroid malignancy. Ann. Intern Med. 69(3), 537\u2013540. https:\/\/doi.org\/10.7326\/0003-4819-69-3-537 (1968).","journal-title":"Ann. Intern Med."},{"issue":"1","key":"10625_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1677\/joe.0.1150053","volume":"115","author":"JA Franklyn","year":"1987","unstructured":"Franklyn, J. A. et al. Modulation by estrogen of thyroid hormone effects on thyrotrophin gene expression. J. Endocrinol. 115(1), 53\u201359. https:\/\/doi.org\/10.1677\/joe.0.1150053 (1987).","journal-title":"J. Endocrinol."},{"issue":"11","key":"10625_CR4","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1210\/jc.2007-0287","volume":"92","author":"CA Spencer","year":"2007","unstructured":"Spencer, C. A., Hollowell, J. G., Kazarosyan, M. & Braverman, L. E. National health and nutrition examination survey iii thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J. Clin. Endocrinol. Metab. 92(11), 4236\u20134240. https:\/\/doi.org\/10.1210\/jc.2007-0287 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10625_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","volume":"87","author":"JG Hollowell","year":"2002","unstructured":"Hollowell, J. G. et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87(2), 489\u2013499. https:\/\/doi.org\/10.1210\/jcem.87.2.8182 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10625_CR6","first-page":"47","volume":"111","author":"R Lange","year":"1989","unstructured":"Lange, R. & Meinen, K. Diagnosis of thyroid function in uterine myomatosis. Zentralbl Gynakol. 111(1), 47\u201352 (1989).","journal-title":"Zentralbl Gynakol."},{"issue":"11","key":"10625_CR7","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.3390\/ijerph17113821","volume":"17","author":"LM Sun","year":"2020","unstructured":"Sun, L. M., Chung, L. M., Lin, C. L. & Kao, C. H. Uterine fibroids increase the risk of thyroid cancer. Int. J. Environ. Res. Public Health. 17(11), 3821. https:\/\/doi.org\/10.3390\/ijerph17113821 (2020).","journal-title":"Int. J. Environ. Res. Public Health."},{"issue":"7","key":"10625_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1507\/endocrj.k10e-024","volume":"57","author":"MH Kim","year":"2010","unstructured":"Kim, M. H. et al. The relationship between thyroid nodules and uterine fibroids. Endocr. J. 57(7), 615\u2013621. https:\/\/doi.org\/10.1507\/endocrj.k10e-024 (2010).","journal-title":"Endocr. J."},{"issue":"12","key":"10625_CR9","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1089\/thy.2006.0330","volume":"17","author":"N Spinos","year":"2007","unstructured":"Spinos, N. et al. Increased frequency of thyroid nodules and breast fibroadenomas in women with uterine fibroids. Thyroid 17(12), 1257\u20131259. https:\/\/doi.org\/10.1089\/thy.2006.0330 (2007).","journal-title":"Thyroid"},{"key":"10625_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejogrb.2014.03.003","volume":"177","author":"J Ott","year":"2014","unstructured":"Ott, J. et al. Overt hypothyroidism is associated with the presence of uterine leiomyoma: A retrospective analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 177, 19\u201322. https:\/\/doi.org\/10.1016\/j.ejogrb.2014.03.003 (2014).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10625_CR11","doi-asserted-by":"publisher","DOI":"10.4178\/epih\/e2014008","volume":"36","author":"L Kim","year":"2014","unstructured":"Kim, L., Kim, J. A. & Kim, S. A guide for the utilization of health insurance review and assessment service national patient samples. Epidemiol. Health. 36, e2014008. https:\/\/doi.org\/10.4178\/epih\/e2014008 (2014).","journal-title":"Epidemiol. Health."},{"issue":"6","key":"10625_CR12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H. Quan","year":"2011","unstructured":"Quan, H. et al. Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am. J. Epidemiol. 173(6), 676\u2013682. https:\/\/doi.org\/10.1093\/aje\/kwq433 (2011).","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10625_CR13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/s0002-9378(89)80046-8","volume":"160","author":"K Kawaguchi","year":"1989","unstructured":"Kawaguchi, K. et al. Mitotic activity in uterine leiomyomas during the menstrual cycle. Am. J. Obstet. Gynecol. 160(3), 637\u2013641. https:\/\/doi.org\/10.1016\/s0002-9378(89)80046-8 (1989).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10625_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13669-018-0243-5","volume":"7","author":"S Ghosh","year":"2018","unstructured":"Ghosh, S., Naftalin, J., Imrie, R. & Hoo, W. L. Natural history of uterine fibroids: A radiological perspective. Curr. Obstet. Gynecol. Rep. 7(3), 117\u2013121. https:\/\/doi.org\/10.1007\/s13669-018-0243-5 (2018).","journal-title":"Curr. Obstet. Gynecol. Rep."},{"issue":"9","key":"10625_CR15","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1177\/1933719114533728","volume":"21","author":"L Doherty","year":"2014","unstructured":"Doherty, L., Mutlu, L., Sinclair, D. & Taylor, H. Uterine fibroids: clinical manifestations and contemporary management. Reprod. Sci. 21(9), 1067\u20131092. https:\/\/doi.org\/10.1177\/1933719114533728 (2014).","journal-title":"Reprod. Sci."},{"issue":"1","key":"10625_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/thy.2012.0392","volume":"23","author":"N Li","year":"2013","unstructured":"Li, N., Du, X. L., Reitzel, L. R., Xu, L. & Sturgis, E. M. Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: Review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980\u20132008. Thyroid 23(1), 103\u2013110. https:\/\/doi.org\/10.1089\/thy.2012.0392 (2013).","journal-title":"Thyroid"},{"issue":"3","key":"10625_CR17","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1158\/1055-9965.EPI-08-0960","volume":"18","author":"L Enewold","year":"2009","unstructured":"Enewold, L. et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980\u20132005. Cancer Epidemiol. Biomark. Prev. 18(3), 784\u2013791. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0960 (2009).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"1","key":"10625_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/BF03350907","volume":"27","author":"G Costante","year":"2004","unstructured":"Costante, G. et al. Slow growth of benign thyroid nodules after menopause: No need for long-term thyroxine suppressive therapy in postmenopausal women. J. Endocrinol Invest. 27(1), 31\u201336. https:\/\/doi.org\/10.1007\/BF03350907 (2004).","journal-title":"J. Endocrinol Invest."},{"issue":"2","key":"10625_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s12020-014-0342-7","volume":"48","author":"K Wang","year":"2015","unstructured":"Wang, K. et al. The association of menstrual and reproductive factors with thyroid nodules in Chinese women older than 40 years of age. Endocrine 48(2), 603\u2013614. https:\/\/doi.org\/10.1007\/s12020-014-0342-7 (2015).","journal-title":"Endocrine"},{"issue":"4","key":"10625_CR20","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1158\/1940-6207.CAPR-13-0367","volume":"7","author":"MZ Braganza","year":"2014","unstructured":"Braganza, M. Z. et al. Benign breast and gynecologic conditions, reproductive and hormonal factors, and risk of thyroid cancer. Cancer Prev. Res. 7(4), 418\u2013425. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-13-0367 (2014).","journal-title":"Cancer Prev. Res."},{"issue":"5","key":"10625_CR21","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3892\/ijo_00000588","volume":"36","author":"A Kumar","year":"2010","unstructured":"Kumar, A., Klinge, C. M. & Goldstein, R. E. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. Int. J. Oncol. 36(5), 1067\u20131080. https:\/\/doi.org\/10.3892\/ijo_00000588 (2010).","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10625_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/156800908785133150","volume":"8","author":"GG Chen","year":"2008","unstructured":"Chen, G. G., Vlantis, A. C., Zeng, Q. & van Hasselt, C. A. Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Curr. Cancer Drug. Targets. 8(5), 367\u2013377. https:\/\/doi.org\/10.2174\/156800908785133150 (2008).","journal-title":"Curr. Cancer Drug. Targets."},{"issue":"1","key":"10625_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/thy.2009.0296","volume":"20","author":"S Rajoria","year":"2010","unstructured":"Rajoria, S. et al. Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 20(1), 33\u201341. https:\/\/doi.org\/10.1089\/thy.2009.0296 (2010).","journal-title":"Thyroid"},{"issue":"1","key":"10625_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1210\/er.2012-1043","volume":"34","author":"JJ Kim","year":"2013","unstructured":"Kim, J. J., Kurita, T. & Bulun, S. E. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr. Rev. 34(1), 130\u2013162. https:\/\/doi.org\/10.1210\/er.2012-1043 (2013).","journal-title":"Endocr. Rev."},{"issue":"4","key":"10625_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/humupd\/dmi008","volume":"11","author":"A Bouman","year":"2005","unstructured":"Bouman, A., Heineman, M. J. & Faas, M. M. Sex hormones and the immune response in humans. Hum. Reprod. Update. 11(4), 411\u2013423. https:\/\/doi.org\/10.1093\/humupd\/dmi008 (2005).","journal-title":"Hum. Reprod. Update."},{"issue":"2","key":"10625_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00130404-200503000-00006","volume":"11","author":"ML Lee","year":"2005","unstructured":"Lee, M. L. et al. Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL. Cancer J. 11(2), 113\u2013121. https:\/\/doi.org\/10.1097\/00130404-200503000-00006 (2005).","journal-title":"Cancer J."},{"key":"10625_CR27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jtemb.2016.10.006","volume":"39","author":"D Mahapatra","year":"2017","unstructured":"Mahapatra, D. & Chandra, A. K. Biphasic action of iodine in excess at different doses on ovary in adult rats. J. Trace Elem. Med. Biol. 39, 210\u2013220. https:\/\/doi.org\/10.1016\/j.jtemb.2016.10.006 (2017).","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"1","key":"10625_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1210\/er.2001-0029","volume":"24","author":"O Dohan","year":"2003","unstructured":"Dohan, O. et al. The sodium\/iodide Symporter (NIS): Characterization, regulation, and medical significance. Endocr. Rev. 24(1), 48\u201377. https:\/\/doi.org\/10.1210\/er.2001-0029 (2003).","journal-title":"Endocr. Rev."},{"issue":"12","key":"10625_CR29","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1210\/endo.140.12.7197","volume":"140","author":"TW Furlanetto","year":"1999","unstructured":"Furlanetto, T. W., Nguyen, L. Q. & Jameson, J. L. Estradiol increases proliferation and downregulates the sodium\/iodide symporter gene in FRTL-5 cells. Endocrinology 140(12), 5705\u20135711. https:\/\/doi.org\/10.1210\/endo.140.12.7197 (1999).","journal-title":"Endocrinology"},{"issue":"2","key":"10625_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1590\/s0100-879x2001000200015","volume":"34","author":"TW Furlanetto","year":"2001","unstructured":"Furlanetto, T. W., Nunes, R. B. Jr., Sopelsa, A. M. & Maciel, R. M. Estradiol decreases iodide uptake by rat thyroid follicular FRTL-5 cells. Braz. J. Med. Biol. Res. 34(2), 259\u2013263. https:\/\/doi.org\/10.1590\/s0100-879x2001000200015 (2001).","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"4","key":"10625_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.7150\/ijms.5.189","volume":"5","author":"FR Stoddard 2nd","year":"2008","unstructured":"Stoddard, F. R. 2nd., Brooks, A. D., Eskin, B. A. & Johannes, G. J. Iodine alters gene expression in the MCF7 breast cancer cell line: Evidence for an anti-estrogen effect of iodine. Int. J. Med. Sci. 5(4), 189\u2013196. https:\/\/doi.org\/10.7150\/ijms.5.189 (2008).","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10625_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3349\/ymj.2000.41.1.22","volume":"41","author":"JY Kim","year":"2000","unstructured":"Kim, J. Y. & Kim, K. R. Dietary iodine intake and urinary iodine excretion in patients with thyroid diseases. Yonsei Med. J. 41(1), 22\u201328. https:\/\/doi.org\/10.3349\/ymj.2000.41.1.22 (2000).","journal-title":"Yonsei Med. J."},{"issue":"3","key":"10625_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s12020-012-9831-8","volume":"43","author":"R Malboosbaf","year":"2013","unstructured":"Malboosbaf, R., Hosseinpanah, F., Mojarrad, M., Jambarsang, S. & Azizi, F. Relationship between goiter and gender: A systematic review and meta-analysis. Endocrine 43(3), 539\u2013547. https:\/\/doi.org\/10.1007\/s12020-012-9831-8 (2013).","journal-title":"Endocrine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10625-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10625-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10625-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:26:39Z","timestamp":1669343199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10625-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10625"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-10625-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,22]]},"assertion":[{"value":"9 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6620"}}